Global Disposable Ophthalmic Cannulas Market Strategic Research Report
By Type: Curved Ophthalmic Cannulas, Straight Ophthalmic Cannulas
By Application: Refractive Surgery, Cataract Surgery, Glaucoma Surgery, Others
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Bausch + Lomb, Beaver-Visitec International, BD, Teleflex, Tecfen Medical, Accutome, Moria Surgical, Katena, Surgistar, Fabrinal SA, Surtex Instruments, Madhu Instruments, Hurricane Medical, Sidapharm
Vista general
Scope of the Report
The global Disposable Ophthalmic Cannulas market size is predicted to grow from US$ 163 million in 2025 to US$ 300 million in 2032; it is expected to grow at a CAGR of 9.2% from 2026 to 2032.
Disposable Ophthalmic Cannulas are micro-tubes ending in tips which have a plethora of shapes and sizes. They assist surgeons to perform certain tasks (e.g. for the delivery or removal of fluids) in a variety of ophthalmic surgical procedures, such as cataract, refractive, vitreoretinal and glaucoma operations. They are based on a hub which can be attached on top of a sharp pointed instrument in order to be inserted through precise incisions into cavities of the eye or of the surrounding area.
Market Drivers for Disposable Ophthalmic Cannulas
The growing prevalence of ophthalmic disorders, such as cataracts, glaucoma, and diabetic retinopathy, is driving the demand for disposable ophthalmic cannulas. With an increasing aging population globally, there is a higher incidence of age-related eye conditions, which boosts the need for surgical interventions and, consequently, for specialized surgical tools like ophthalmic cannulas. Moreover, the rising adoption of minimally invasive surgical techniques in ophthalmology, coupled with a focus on patient safety and hygiene, is further propelling the demand for disposable cannulas. Since these devices are designed for single use, they help reduce the risk of cross-contamination and infections, which is a key driver in their growing market acceptance.
Challenges in the Disposable Ophthalmic Cannulas Market
One of the primary challenges in the disposable ophthalmic cannulas market is the high cost of advanced ophthalmic surgical tools, which can limit their adoption, particularly in developing regions. Although disposable cannulas are cost-effective in terms of infection prevention, the initial price may still be prohibitive for some healthcare facilities, especially in low-income countries. Additionally, concerns over environmental sustainability are emerging, as the large-scale use of single-use plastic products contributes to medical waste. As a result, there is growing pressure on manufacturers to develop eco-friendly alternatives while maintaining the safety and performance standards of disposable ophthalmic cannulas.
APAC is the largest consumption place, with a consumption market share nearly 42.79% in 2023. Following APAC, Americas is the second largest consumption place with the consumption market share of 28.97%.Market competition is intense. Bausch + Lomb, Beaver-Visitec International, BD, Teleflex, Tecfen Medical, etc. are the leaders of the industry, with high-end customers. The top five manufacturers held 72.59% of the market, in terms of Ophthalmic Cannulas revenue in 2023.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Disposable Ophthalmic Cannulas market?
What factors are driving Disposable Ophthalmic Cannulas market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Disposable Ophthalmic Cannulas market opportunities vary by end market size?
How does Disposable Ophthalmic Cannulas break out by Type, by Application?
This report presents a comprehensive overview of the global Disposable Ophthalmic Cannulas market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Curved Ophthalmic Cannulas
- Straight Ophthalmic Cannulas
Segment by Application
- Refractive Surgery
- Cataract Surgery
- Glaucoma Surgery
- Others
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Disposable Ophthalmic Cannulas market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Refractive Surgery, Cataract Surgery, Glaucoma Surgery evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Disposable Ophthalmic Cannulas Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Curved Ophthalmic Cannulas
- 3.1.3 Straight Ophthalmic Cannulas
- 3.1.4 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Refractive Surgery
- 4.1.3 Cataract Surgery
- 4.1.4 Glaucoma Surgery
- 4.1.5 Others
- 4.1.6 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Bausch + Lomb
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Beaver-Visitec International
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 BD
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Teleflex
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Tecfen Medical
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Accutome
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Moria Surgical
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Katena
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Surgistar
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Fabrinal SA
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Surtex Instruments
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Madhu Instruments
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Hurricane Medical
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Sidapharm
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the current global Disposable Ophthalmic Cannulas market size?
What growth rate is expected for the Disposable Ophthalmic Cannulas market through 2032?
How is Disposable Ophthalmic Cannulas defined?
What are the main segments of the Disposable Ophthalmic Cannulas market by type?
Which applications drive demand in the Disposable Ophthalmic Cannulas market?
Who are the key players in the Disposable Ophthalmic Cannulas market?
Which regions and countries are covered for Disposable Ophthalmic Cannulas?
What is driving growth in the Disposable Ophthalmic Cannulas market?
What challenges does the Disposable Ophthalmic Cannulas market face?
Who should buy the Disposable Ophthalmic Cannulas market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Disposable Ophthalmic Cannulas Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Healthcare & Medical Devices